PTEN somatic down-regulation has been linked to tumours, neural proliferation and is being proposed as a target for neuroprotection in PD cases (26,27), whereas PTEN mutations in the germline have been linked to developmental neurological diseases (28). This evidence concerns the gene PTEN and neoplasm.